Maui Health Now Offering Monoclonal Antibody Treatment
Maui Health has partnered with Kaiser Permanente to offer outpatient monoclonal antibody treatment to Maui residents.
Monoclonal antibody treatment (mAb) is a form of immunotherapy to fight viral infections and has been shown to reduce the risk of severe illness and hospitalization from COVID-19 by as much as 70%.
If you recently tested positive for COVID-19 and are at high risk for severe illness, you may qualify for monoclonal antibody (mAb) treatment. To qualify, patients must be:
- Within ten (10) days of start of mild to moderate symptoms, AND
- At high risk for severe illness, including BMI greater than 25, chronic kidney disease,
diabetes, immunocompromised disorders, and other chronic health conditions.
The new treatment center operates seven days a week from 8:00 a.m. to 4:30 p.m. at Kaiser Permanente’s Maui Lani Medical Office with assistance from Federal Emergency Management Agency (FEMA) nurses provided by Maui Health.
To learn how to schedule an appointment and for a complete list of qualified risk factors and criteria, please visit www.mauihealth.org/mab.